D-Tryptophan ethyl ester hydrochloride is distributed as a white to off-white crystalline powder with the molecular formula C₁₃H₁₆N₂O₂·HCl and a molar mass of 268.74 g/mol. The product is the D-(R)-enantiomer of tryptophan in which the carboxyl group is protected as an ethyl ester and the α-amino group is present as the hydrochloride salt. This salt form provides a defined crystalline protonation state that improves storage, dispensing, and solids transfer relative to the free amino ester, while still allowing selective N-acylation after neutralization. Solubility is typically high in water, methanol, ethanol, and dimethyl sulfoxide; solubility in nonpolar solvents such as heptane or toluene is limited. No unified industry model number applies, because supplier catalogue codes and grade suffixes vary, but the chemical identity is fixed by the molecular formula, enantiomeric ratio, and salt stoichiometry. Routine release documentation normally includes HPLC purity of ≥98.0% or ≥99.0%, enantiomeric excess of ≥99.0%, residual water by Karl Fischer titration of ≤0.5%, and residual solvent levels evaluated under ICH Q3C guidance. Specific rotation is reported on the certificate of analysis as [α]_D²⁰; acceptance limits should be fixed against a qualified reference lot because the numerical value can shift with solvent, concentration, and counterion hydration. The product is typically packaged in amber glass or double polyethylene-lined drums under nitrogen and stored at 2–8 °C in a desiccated environment.

Where Does the D-Ethyl Ester Hydrochloride Enter Synthetic Workflows?

The compound functions as a carboxyl-protected chiral building block for introducing a non-natural tryptophan residue into peptide chains, peptidomimetics, and tryptophan-derived heterocycles. In solution-phase peptide synthesis, the hydrochloride salt is neutralized with a tertiary amine before coupling; N,N-diisopropylethylamine is commonly charged at 1.0–1.5 equivalents relative to the hydrochloride. Carbodiimide reagents such as N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride activate the carboxyl component, while additives such as 1-hydroxybenzotriazole or 1-hydroxy-7-azabenzotriazole reduce racemization of the activated amino acid. The D-Trp-OEt substrate is dissolved in anhydrous dichloromethane or N,N-dimethylformamide at 0–5 °C and added to the activated acid. During the coupling step the ethyl ester remains intact; it can be removed subsequently by saponification with aqueous lithium hydroxide in tetrahydrofuran-water at 0–10 °C. Endpoint monitoring by HPLC at 280 nm quantifies disappearance of the starting ester and formation of the free acid. The lower hydrolysis rate of the ethyl ester compared with the methyl ester allows controlled C-terminal deprotection, provided the pH is held below 12 and temperature is maintained at or below 10 °C. For pilot-scale operation, a jacketed glass-lined reactor with nitrogen inerting and a retreat-curve impeller is typical; the neutralization exotherm and saponification exotherm require controlled cooling and staged base addition. If coupling is attempted without prior amine neutralization, the free-base concentration remains too low for efficient amide bond formation and the released chloride can interfere with certain catalysts. The hydrochloride salt is therefore not charged directly into carbodiimide-mediated coupling as the sole amine source.

Identity is normally supported by positive-ion electrospray mass spectrometry; the free ester derived from the hydrochloride salt produces an [M+H]⁺ ion at m/z 233.13. The ultraviolet absorption maximum at 280 nm is suitable for HPLC quantification. Infrared spectroscopy shows the ethyl ester carbonyl absorption in the 1720–1750 cm^-1 region. Because the D and L enantiomers possess identical mass and UV spectra, enantiomeric excess is assessed by chiral HPLC on a polysaccharide-based chiral stationary phase rather than by optical rotation alone. Polarimetric data remain part of release testing, but the sign and magnitude must be interpreted against the specified solvent, concentration, and counterion form. The theoretical chloride content of the anhydrous hydrochloride salt is 13.19%, and chloride assay by argentometric titration or ion chromatography is often used as an orthogonal stoichiometric check. Published data for the complete long-term degradation profile of this specific enantiomeric configuration is limited; therefore, the certificate of analysis and retest date should be verified for each batch before use in regulated intermediate synthesis.

Release Specification Matrix and Orthogonal Identity Tests

The following table summarizes the typical release specification matrix for D-tryptophan ethyl ester hydrochloride. Supplier-specific acceptance windows may be tighter than the values shown, particularly for residual solvents and chromatographic purity in custom synthesis grades.

Selection of the D-enantiomer rather than the L-isomer is made when the target structure requires a non-natural residue. D-Tryptophan ethyl ester hydrochloride has the same molecular formula and molar mass as L-tryptophan ethyl ester hydrochloride, but the absolute configuration at the α-carbon is reversed. Under standard amino acid nomenclature, the D-tryptophan derivative carries the (R)-configuration, whereas L-tryptophan is (S). In peptide coupling, D-tryptophan incorporation can reduce recognition by L-selective endogenous proteases and alter backbone conformation; these effects are sequence-dependent and must be confirmed in the specific target. The racemic DL-tryptophan ethyl ester hydrochloride is a mixture of both enantiomers and generally requires preparative chiral chromatography or a resolving agent to isolate the D-enantiomer. If the chromatographic separation factor α is below 1.2, preparative resolution can become cost-prohibitive, and downstream enantiomeric purity can be difficult to maintain without additional chiral controls. Use of enantiopure D-tryptophan ethyl ester hydrochloride avoids the preparative resolution step and reduces the analytical burden in later intermediates. For solid-phase synthesis, the free carboxyl of tryptophan is often immobilized as a resin ester or amide; the ethyl ester hydrochloride is used mainly in solution-phase routes or to prepare N-protected building blocks such as Fmoc-D-Trp-OEt or Boc-D-Trp-OEt.

When the Ethyl Ester Hydrochloride Replaces the Free Base or Methyl Ester in Process-Scale Synthesis

Replacement of D-tryptophan free base with the ethyl ester hydrochloride introduces a carboxyl-protected, crystalline salt. The free base is an amphoteric solid with high melting character and lower organic-solvent solubility; the hydrochloride salt is generally easier to charge through a nitrogen-purged solids port because it does not form the same electrostatic or hygroscopic agglomerates. Replacement of the corresponding methyl ester hydrochloride with the ethyl ester hydrochloride changes the hydrolytic leaving group from methanol to ethanol. Under ICH Q3C, methanol is a Class 2 residual solvent with a permitted daily exposure of 30 mg/day, while ethanol is a Class 3 residual solvent with a permitted daily exposure of 50 mg/day; this difference can simplify solvent control when the ester is cleaved downstream. The molecular mass difference is 14.03 g/mol, from 254.71 g/mol for D-tryptophan methyl ester hydrochloride to 268.74 g/mol for the ethyl ester hydrochloride. Alkaline hydrolysis of the ethyl ester is somewhat slower than that of the methyl ester, but the resulting process window remains narrow because α-carbon racemization and indole oxidation can occur under strongly basic conditions.

Open handling at relative humidity above 60% should be avoided unless pre-drying is performed according to the supplier’s drying instruction. The compound is incompatible with strong aqueous bases at elevated temperature because ester hydrolysis and indole oxidation can proceed simultaneously. It should not be stored in contact with primary or secondary amines under warm, humid conditions, since slow aminolysis of the ethyl ester can occur. On pilot-scale charging lines, the hydrochloride salt is generally free-flowing after milling or sieving; prolonged storage may produce soft agglomerates that should be screened before charging to a reactor. The material is a chemical intermediate, not a finished pharmaceutical preparation, and must be purified, assayed, and released according to the downstream process validation. If the target sequence requires N-acylation, the free amine can be protected as an Fmoc or Boc derivative in a separate step before peptide coupling; for example, treatment with Fmoc-OSu in a two-phase water/dioxane system after neutralization gives Fmoc-D-Trp-OEt. In such transformations, control of the aqueous pH below 9 during the protection step reduces premature ethyl ester cleavage. The chiral integrity of the D-tryptophan ethyl ester hydrochloride should be confirmed after any prolonged exposure to base, rather than assumed from the incoming certificate of analysis.